Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial [version 2; peer review: 1 approved, 1 approved with reservations]
Journal article published in 2023 by
Mainga Hamaluba 
,
Samuel Sang,
Benedict Orindi,
Irene Njau,
Henry Karanja,
Naomi Kamau,
John N. Gitonga,
Daisy Mugo,
Daniel Wright,
Alun Davies,
James Nyagwange,
Bernadette Kutima,
Nadia Aliyan,
Anthony Etyang,
Donwilliams Omuoyo
and other authors.
,
Samuel Sang,
Benedict Orindi,
Irene Njau,
Henry Karanja,
Naomi Kamau,
John N. Gitonga,
Daisy Mugo,
Daniel Wright,
Alun Davies,
James Nyagwange,
Bernadette Kutima,
Nadia Aliyan,
Anthony Etyang,
Donwilliams Omuoyo
and other authors.
